Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZX-7101A in adults with uncomplicated influenza
NCT05702489Phase 3Completed
- Sponsor
- Zenshine Pharmaceuticals Co., Ltd.
- Start
- Jul 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Seloxavir marboxil in influenza, sponsored by Zenshine Pharmaceuticals Co., Ltd.. Started Jul 2022; status: completed.
02
Drugs
Seloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05702489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05702489.